<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The basic characteristics of granulo-macrophage colony stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF) are reviewed </plain></SENT>
<SENT sid="1" pm="."><plain>The structure of the proteins and genes have been clarified </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical use of these hematopoietic growth factors are also discussed </plain></SENT>
<SENT sid="3" pm="."><plain>Diseases for which these growth factors will be effective are follows, the granulocytepenic state after anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapy, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, bone marrow transplantation and so on </plain></SENT>
<SENT sid="4" pm="."><plain>As these growth factors increase the granulocyte function, these proteins will be effective on the immunodifective state </plain></SENT>
</text></document>